🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Smoking & cancer: a strong link. 1 in 2 cancer patients had smoked. 1 in 7 still smoked at diagnosis. Quitting helps treatment & survival. It’s never too late. #Cancer #smoking JAMA Oncology World Health Organization (WHO) OncoAlert jamanetwork.com/journals/jamao…

Final results from #METex14 cohort of CHRYSALIS JTO & JTO CRR - amivantamab monotherapy in 97 pts with NSCLC and a MET exon 14 skip mutation. RR 32% with DOR 11.2m and PFS 5.3m. RR 50% as first-line; RR 19% if prior MET directed therapy given. jto.org/article/S1556-…

Join us for one of the final webinars of Thymic Malignancy Awareness Month: 'Treatment of Thymic Epithelial Tumors in the Era of the 9th Edition TNM: The Current State of the Art', featuring three leading experts! Register: bit.ly/4k61kOK ITMIG Society

We are heading to #ASCO25 with more than 80 rising hemeonc fellowship applicants. We encourage fellowship programs to reach out to applicants, help answer questions & mingle. #Unity #Diversity #Equity #Inclusion #Mentorship #Education #Fellowship #Hemeonc #Community #MedTwitter

Y’all we have two, one, two days left to vote! If you are an IASLC member 🏃 please to you inbox and fill out your ballot for the #IASLC25 board. Narjust Florez, MD, FASCO is throwing her stethoscope in for the undesignated board seat #4 spot, so head to your portal and vote vote vote.

Amivantamab y Manejo de Toxicidades - Videoteca de Cáncer de Pulmón en Español 2025 - youtu.be/LAT1y15YMTQ En este video, el Dr. Dr. Luis E. Raez analiza cómo utilizar Amivantamab y controlar las toxicidades. Transcripción del video: drive.google.com/file/d/1-2z0T9… Visita

👀

Terapia para Pacientes con Tumores No Tratables - Videoteca de Cáncer de Pulmón en Español 2025 - youtu.be/e06YIb81QWc En este video, la Dra. Ivy Riano, M.D. analiza la mejor inmunoterapia de primera línea para pacientes con tumores no tratables en estadio avanzado de cáncer de

ToxCheck series: Common anti-EGFR drugs we use for mEGFR non-small cell #LungCancer w/ gilberto lopes ✅ Afatinib ✅ Osimertinib ✅ Amivantamab + Lazertinib Full discussion: ⭐️ oncbrothers.com/egfr-toxcheck-… ⭐️ Also on the “Oncology Brothers” podcast #lcsm #OncTwitter OncUpdates

#ASCO25 So excited to speak at this session with one of my #SoMe heroes 🤩Mark Lewis, MD, FASCO who I hear is a sigma influencer and will “slay” this talk on Leveraging Social Media for your Career: the Good and Bad side of Social Media and how to make it work for you. thanks for x.com/dawood_findakl…

I wish they had ASCO TECAG when I was a fellow- what a great group to help trainees to make the most of what can be an overwhelming meeting #ASCO25

I am honored to be a #ASCO25 Featured Voice! I will amplify trainee posts and research on #DrugDevelopment, #SurvOnc and global oncology. 📢 Hosting the BlueSky Takeover for ASCO about “AI and Cancer Care” on June 1 at 4:30 PM #Oncology #GlobOnc #ClinicaPharmacology #oncologia

ALCSI is so grateful to have your support in raising #lungcancerawareness! Thank you for sharing!

🌴Sylvester Comprehensive Cancer Center #MiamiNights 🌴are back during #ASCO25! We are proud to celebrate a number of poster and oral presentations from our investigators ! Follow us for updates and join us at Miami Nights to connect w our team (space is limited sign up here) 👇🏽👇🏽

Happening now! #ASCO25

👀The anticipation for the ASCO #ASCO25 abstract release at 5PM ET today is growing❗️. Thanks for compiling this list Ben Creelan, MD

Great discussion with Oncology Brothers and our very own gilberto lopes Sylvester Comprehensive Cancer Center on EGFR therapies & toxicity management EGFR Resisters #lcsm

👏👏On making guidelines more accessible for busy oncologists: ASCO and Google create ‘walled garden’ AI tool for doctors to query group’s #ASCOguidelines statnews.com/2025/05/21/asc… via STAT

Alright #ASCO25 @asco abstracts are out (minus LBA) meetings.asco.org/abstracts-pres… Tell us about your favorites as we start the countdown gilberto lopes